A routine question during an eye exam, “Do you smoke, or did you ever?”, now carries far more weight than most patients ...

Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...

Add Yahoo as a preferred source to see more of our stories on Google. Your eyesight is precious! So you want to do everything possible to avoid the changes you’re told are a normal part of aging — ...

Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care uveitis practice demonstrate outcomes consistent with results from the U.S. Phase 1b APEX study, supp ...

Damon Wayans Sr. has spoken about how urging from loved ones and personal health scares led him to address his type 2 diabetes and its potential complications. Since his diagnosis, he has partnered ...

Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive ...

ORLANDO, Fla. (Ivanhoe Newswire) - There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it happens when small deposits form under ...

Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the ...

A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related ...

Researchers have found in a prospective study of 550 cases that the double-layer sign on optical coherence tomography (OCT), ...

Ocular Therapeutix has initiated a long-term extension trial evaluating the investigational intravitreal therapy AXPAXLI in ...